# K150252: PHALINX Hammertoe System

- Pathway: 510(k) (Traditional)
- Applicant: Wrightmedicaltechnologyinc
- Decided: Apr 29, 2015 after 85 days
- Product code: HWC (Screw, Fixation, Bone)
- Device class: 2
- Regulation: 21 CFR 888.3040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K013888 (2002). 21 ancestors in all.
6 later devices descend from it; 3 cite it directly.
0 of 28 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K142585: PhaLinx Hammertoe System, Wrightmedicaltechnologyinc (2014) Summary page 4.
- K140148: Pro-Toe Hammertoe Fixation System, Wrightmedicaltechnologyinc (2014) Summary page 4.
- K132895: WMT Implantable K-Wire, Wrightmedicaltechnologyinc (2013) Summary page 4.

## Most influential descendants
- K200840: DuoHex CH Cannulated Hammertoe System (2020), 3 descendants of its own
- K213530: Nextra CH Cannulated Hammertoe System (2021), 1 descendant of its own
- K221610: Nextra CH Cannulated Hammertoe System (2022), 0 descendants of its own
- K212996: Sterile PHALINX Hammertoe System (2021), 0 descendants of its own
- K211996: Nexta PEEK Hammertoe Correction System (2021), 0 descendants of its own

## Indications for use
The PHALINX® Hammertoe System is indicated for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe, and mallet toe. Cannulated Implants in the PHALINX® Hammertoe Fixation System can be used with k-wires for the delivery of implants or the temporary stabilization of outlying joints (e.g. MTP Joint).

Source page: https://510kreport.com/device/K150252
Methodology: https://510kreport.com/methodology